Work

Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of Bendamustine in Combination with Lenalidomide and Dexamethasone (BRD) in Patients with Relapsed Multiple Myeloma: A Multiple Myeloma Research Consortium Study.

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.2965.2965

Authors: Shaji K. Kumar, Amrita Krishnan, Vivek Roy, Todd M Zimmerman, Morie Abraham A Gertz, Keith E. Stockerl-Goldstein, Francis K Buadi, Cara Rosenbaum, Ann Birgin, Mark Fiala, Valeria Jiminez, Michele Maharaj, Michael N. Needle, Ravi Vij

Institutions: Mayo Clinic, City Of Hope National Medical Center, City of Hope, Mayo Clinic in Florida, University of Chicago, Washington University in St. Louis, University of Chicago Medical Center, Multiple Myeloma Research Foundation

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2572116053

FWCI: 0.577

Cites:

Cited by: 3

Related to: 10